Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exir Saffron is a specialized healthcare company focused on the development and distribution of high-potency saffron-based nutraceuticals. The company leverages the therapeutic properties of Crocus sativus and its active bio-compounds, such as crocin and safranal, to provide natural solutions for mental health and ocular wellness. Their product portfolio is designed to address conditions such as depression, anxiety, and age-related macular degeneration through standardized, bioavailable formulations. Exir Saffron emphasizes rigorous quality control and sourcing to ensure the purity and efficacy of its saffron extracts. The company serves a global consumer base seeking science-backed botanical supplements for neurological and physiological support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exir Saffron.